Please wait while the formulary information is being retrieved.
VIAGRA (SILDENAFIL CITRATE)
- Erectile dysfunction
100 mg tablet
- 1 tablet (100 mg) by oral route once daily as needed approximately 1 hour before sexual activity
25 mg tablet
- 1 tablet (25 mg) by oral route once daily as needed approximately 1 hour before sexual activity
50 mg tablet
- 1 tablet (50 mg) by oral route once daily as needed approximately 1 hour before sexual activity
100 mg tablet
- 1 tablet (100 mg) by oral route once daily as needed approximately 1 hour before sexual activity
25 mg tablet
- 1 tablet (25 mg) by oral route once daily as needed approximately 1 hour before sexual activity
50 mg tablet
- 1 tablet (50 mg) by oral route once daily as needed approximately 1 hour before sexual activity
sildenafil 100 mg tablet
- 1 tablet (100 mg) by oral route once daily as needed approximately 1 hour before sexual activity
sildenafil 25 mg tablet
- 1 tablet (25 mg) by oral route once daily as needed approximately 1 hour before sexual activity
sildenafil 50 mg tablet
- 1 tablet (50 mg) by oral route once daily as needed approximately 1 hour before sexual activity
Erectile dysfunction
- 1 tablet (25 mg) by oral route once daily as needed approximately 1 hour before sexual activity
- 2 tablets (50 mg) by oral route once daily as needed approximately 1 hour before sexual activity
- 1 tablet (50 mg) by oral route once daily as needed approximately 1 hour before sexual activity
- 2 tablets (100 mg) by oral route once daily as needed approximately 1 hour before sexual activity
- 1 tablet (100 mg) by oral route once daily as needed approximately 1 hour before sexual activity
- Adempas
- Bidil
- Dilatrate-sr
- Imdur
- Isochron
- Isoditrate
- isosorbide dinitrate
- isosorbide mononitrate
- isosorbide-hydralazine
- Korlym
- Mifeprex
- mifepristone
- Minitran
- Nithiodote
- Nitro-bid
- Nitro-dur
- Nitro-time
- nitroglycerin
- nitroglycerin in 5 % dextrose
- Nitrolingual
- Nitromist
- Nitropress
- nitroprusside
- Nitrostat
- riociguat
- sodium nitrite
- sodium nitrite-sod thiosulfate
Contraindicated
- None
Severe
Moderate
- alfuzosin
- amoxicil-clarithromy-lansopraz
- atazanavir
- Biaxin
- Biaxin Xl
- Biaxin Xl Pak
- boceprevir
- Cardura
- Cardura Xl
- Cipro
- Cipro In D5W
- Cipro Xr
- ciprofloxacin
- ciprofloxacin (mixture)
- ciprofloxacin in D5W
- clarithromycin
- Crixivan
- delavirdine
- Dibenzyline
- doxazosin
- dutasteride-tamsulosin
- elvitegr-cobicist-emtric-tenof
- Flomax
- fosamprenavir
- Incivek
- indinavir
- itraconazole
- Jalyn
- Kaletra
- Ketek
- ketoconazole
- Lexiva
- lopinavir-ritonavir
- Minipress
- nefazodone
- nelfinavir
- Norvir
- Norvir Soft Gelatin
- Omeclamox-pak
- omeprazole-clarith-amoxicillin
- Onmel
- phenoxybenzamine
- phentolamine
- prazosin
- Prevpac
- Rescriptor
- Reyataz
- ritonavir
- Sporanox
- Sporanox Pulsepak
- Stribild
- tamsulosin
- telaprevir
- telithromycin
- terazosin
- Uroxatral
- Victrelis
- Viracept
- Anterior ischemic optic neuropathy
- Hereditary retinal dystrophy
- Pulmonary veno-occlusive disease
Contraindicated
- Acute myocardial infarction
- Disease of liver
- Esophageal dysmotility
- Hypertrophic cardiomyopathy
- Life-threatening cardiac arrhythmias
- Severe renal impairment
Severe
Moderate
- Aortic valve stenosis
- Cerebrovascular accident
- Chronic heart failure
- Fibrosis of corpus cavernosum
- Hearing loss
- Hypotension
- Leukemia
- Multiple myeloma
- Penile angulation
- Peyronie's disease
- Pigmentary retinopathy
- Severe autonomic insufficiency
- Severe uncontrolled hypertension
- Sickle cell disease
- Unstable angina pectoris
VIAGRA (SILDENAFIL CITRATE)
- Erectile dysfunction
- None
- Back pain
- Dizziness
- Dyspepsia
- Edema
- Epistaxis
- Flushing
- Headache disorder
- Nasal congestion
- Nausea
More Frequent
Severe
Less Severe
- Upper respiratory infection
- Visual changes
- Diarrhea
- Dyspnea
- Erythema
- Fever
- Flu-like symptoms
- Insomnia
- Rhinitis
- Sinusitis
- Skin rash
- Urinary tract infection
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Acute myocardial infarction
- Anemia
- Angina
- Anterior ischemic optic neuropathy
- Ataxia
- Atrioventricular block
- Cardiac arrest
- Cardiomyopathy
- Cataracts
- Cerebral thrombosis
- Chest pain
- Chronic heart failure
- Cystitis
- Depression
- Esophagitis
- Exfoliative dermatitis
- Hearing loss
- Hyperglycemia
- Hypernatremia
- Hypertension
- Hypertonia
- Hyperuricemia
- Hypoglycemic disorder
- Hypotension
- Intracerebral hemorrhage
- Leukopenia
- Myocardial ischemia
- Ocular hemorrhage
- Ocular hypertension
- Orthostatic hypotension
- Pain
- Palpitations
- Peripheral edema
- Priapism
- Pulmonary hemorrhage
- Rectal bleeding
- Retinal edema
- Retinal hemorrhage
- Seizure disorder
- Shock
- Syncope
- Tachycardia
- Tendon rupture
- Transient cerebral ischemia
- Uncontrolled diabetes mellitus
- Urinary incontinence
- Ventricular arrhythmias
- Vision loss
- Vitreous detachment
Less Severe
- Abnormal sexual function
- Acute abdominal pain
- Arthritis
- Asthma
- Bone pain
- Bronchitis
- Chills
- Colitis
- Conjunctivitis
- Contact dermatitis
- Cough
- Disorder of ejaculation
- Dream disorder
- Drowsy
- Dry eye
- Dysphagia
- Earache
- Edema of male genital organs
- Facial edema
- Gastritis
- Gastroenteritis
- General weakness
- Gingivitis
- Glossitis
- Gout
- Gynecomastia
- Hematuria
- Hyperhidrosis
- Hypesthesia
- Hyporeflexia
- Increased sputum
- Increased urinary frequency
- Laryngitis
- Migraine
- Muscle weakness
- Myalgias
- Mydriasis
- Neuralgia
- Nocturia
- Ocular pain
- Orgasm disorder
- Paresthesia
- Peripheral sensory neuropathy
- Pharyngitis
- Photophobia
- Polydipsia
- Pruritus of skin
- Skin photosensitivity
- Skin ulcer
- Stomatitis
- Symptoms of anxiety
- Synovitis
- Tenosynovitis
- Testicular swelling
- Tinnitus
- Transient global amnesia
- Tremor
- Urticaria
- Vertigo
- Vomiting
- Xerostomia
Contraindicated
None
Severe Precaution
Sildenafil
Not recommended for chronic treatment. Limited safety data on dose/duration. Increased mortality observed with high dose treatment of PAH and longer duration of therapy.
- 1 Day – 18 Years
- Not recommended for chronic treatment. Limited safety data on dose/duration. Increased mortality observed with high dose treatment of PAH and longer duration of therapy.
Management or Monitoring Precaution
None
Sildenafil
- Severity Level:
2
- Additional Notes: Insufficient human data; consider maternal benefit vs. pot fetal/neonatal risks
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Sildenafil
Limited data suggest minimal excretion, with unknown effect on infant
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Not known; no or inclusive data | Limited data suggest minimal excretion, with unknown effect on infant |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Sildenafil
Hepatic-Consider dose reduction with hepatic impairment. Renal-Consider dose reduction with severe renal impairment.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | Y | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Erectile dysfunction | |
| F52.21 | Male erectile disorder |
| N52 | Male erectile dysfunction |
| N52.0 | Vasculogenic erectile dysfunction |
| N52.01 | Erectile dysfunction due to arterial insufficiency |
| N52.02 | Corporo-venous occlusive erectile dysfunction |
| N52.03 | Combined arterial insufficiency and corporo-venous occlusive erectile dysfunction |
| N52.1 | Erectile dysfunction due to diseases classified elsewhere |
| N52.2 | Drug-induced erectile dysfunction |
| N52.3 | Postprocedural erectile dysfunction |
| N52.31 | Erectile dysfunction following radical prostatectomy |
| N52.32 | Erectile dysfunction following radical cystectomy |
| N52.33 | Erectile dysfunction following urethral surgery |
| N52.34 | Erectile dysfunction following simple prostatectomy |
| N52.35 | Erectile dysfunction following radiation therapy |
| N52.36 | Erectile dysfunction following interstitial seed therapy |
| N52.37 | Erectile dysfunction following prostate ablative therapy |
| N52.39 | Other and unspecified postprocedural erectile dysfunction |
| N52.8 | Other male erectile dysfunction |
| N52.9 | Male erectile dysfunction, unspecified |
| 0-9 | A-Z |
|---|---|
| F52.21 | Male erectile disorder |
| N52 | Male erectile dysfunction |
| N52.0 | Vasculogenic erectile dysfunction |
| N52.01 | Erectile dysfunction due to arterial insufficiency |
| N52.02 | Corporo-venous occlusive erectile dysfunction |
| N52.03 | Combined arterial insufficiency and corporo-venous occlusive erectile dysfunction |
| N52.1 | Erectile dysfunction due to diseases classified elsewhere |
| N52.2 | Drug-induced erectile dysfunction |
| N52.3 | Postprocedural erectile dysfunction |
| N52.31 | Erectile dysfunction following radical prostatectomy |
| N52.32 | Erectile dysfunction following radical cystectomy |
| N52.33 | Erectile dysfunction following urethral surgery |
| N52.34 | Erectile dysfunction following simple prostatectomy |
| N52.35 | Erectile dysfunction following radiation therapy |
| N52.36 | Erectile dysfunction following interstitial seed therapy |
| N52.37 | Erectile dysfunction following prostate ablative therapy |
| N52.39 | Other and unspecified postprocedural erectile dysfunction |
| N52.8 | Other male erectile dysfunction |
| N52.9 | Male erectile dysfunction, unspecified |
Formulary Reference Tool